PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Detail   |   Print    Next page > 
     
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury
2025-07-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market
2025-07-28T    Biotechnology   Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics 
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)
2025-07-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Herbalgy x TEEMTONEfai Make a Groundbreaking Crossover Debut Cool Vibes to Welcome Herbalgy Trophy
2025-07-28T    Food/Beverages   Health Care/Hospital   Retail 
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug
2025-07-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Interventional Robot's RCT Research Published in JNIS, a Leading Journal in Neurointervention!
2025-07-28T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
2025-07-28T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat
2025-07-28T    Health Care/Hospital   Medical/Pharmaceuticals 
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis
2025-07-28T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'
2025-07-28T    Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.